This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

Relationship: 3833

Title

A descriptive phrase which clearly defines the two KEs being considered and the sequential relationship between them (i.e., which is upstream, and which is downstream). More help

Suppression, Estrogen receptor (ER) activity leads to Epigenetic modification process

Upstream event
The causing Key Event (KE) in a Key Event Relationship (KER). More help
Downstream event
The responding Key Event (KE) in a Key Event Relationship (KER). More help

Key Event Relationship Overview

The utility of AOPs for regulatory application is defined, to a large extent, by the confidence and precision with which they facilitate extrapolation of data measured at low levels of biological organisation to predicted outcomes at higher levels of organisation and the extent to which they can link biological effect measurements to their specific causes.Within the AOP framework, the predictive relationships that facilitate extrapolation are represented by the KERs. Consequently, the overall WoE for an AOP is a reflection in part, of the level of confidence in the underlying series of KERs it encompasses. Therefore, describing the KERs in an AOP involves assembling and organising the types of information and evidence that defines the scientific basis for inferring the probable change in, or state of, a downstream KE from the known or measured state of an upstream KE. More help

AOPs Referencing Relationship

AOP Name Adjacency Weight of Evidence Quantitative Understanding Point of Contact Author Status OECD Status
Suppression, Estrogen receptor (ER) activity leads to Impaired, Spermatogenesis via epigenetic modifications adjacent Moderate John Frisch (send email) Under development: Not open for comment. Do not cite

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) that help to define the biological applicability domain of the KER.In general, this will be dictated by the more restrictive of the two KEs being linked together by the KER.  More help
Term Scientific Term Evidence Link
mammals mammals High NCBI
Vertebrates Vertebrates Moderate NCBI

Sex Applicability

An indication of the the relevant sex for this KER. More help
Sex Evidence
Unspecific High

Life Stage Applicability

An indication of the the relevant life stage(s) for this KER.  More help
Term Evidence
All life stages Moderate

Key Event Relationship Description

Provides a concise overview of the information given below as well as addressing details that aren’t inherent in the description of the KEs themselves. More help

Estrogen receptors (ER) are nuclear transcription factors involved in regulation of many physiological processes in vertebrates through signalling.  There are two main types of estrogen receptors, estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) receptors.  Binding by estrogen activates estrogen receptor activity.  Suppression of estrogen receptor activity occurs when a stressor hinders estrogen binding to estrogen receptors or when estrogen levels are diminished, resulting in lowered estrogen receptor activity.

Epigenetic modifications are alterations that affect gene expression without altering the underlying gene sequence.  Among some of the more common processes that lead to epigenetic modifications are DNA methylation and alteration of histone proteins.  DNA methylation involves addition of methyl groups to DNA which causes increased or decreased gene expression.  Histone proteins are small proteins that assist gene expression, DNA repair, and DNA replication; histones can be modified by the addition of methyl, acetyl, or phosphate groups, which accelerates or slows DNA expression, repair, and replication.   

Evidence Collection Strategy

Include a description of the approach for identification and assembly of the evidence base for the KER. For evidence identification, include, for example, a description of the sources and dates of information consulted including expert knowledge, databases searched and associated search terms/strings.  Include also a description of study screening criteria and methodology, study quality assessment considerations, the data extraction strategy and links to any repositories/databases of relevant references.Tabular summaries and links to relevant supporting documentation are encouraged, wherever possible. More help

This Key Event Relationship was part of an Environmental Protection Agency effort to develop AOPs that establish scientifically supported causal linkages between alternative endpoints measured using new approach methodologies (NAMs) and guideline apical endpoints measured in Tier 1 and Tier 2 test guidelines (U.S. EPA, 2025) employed by the Endocrine Disruptor Screening Program (EDSP). A series of key events that represent significant, measurable, milestones connecting molecular initiation to apical endpoints indicative of adversity were identified based on scientific review articles and empirical studies. Additionally, scientific evidence supporting the causal relationships between each pair of key events was assembled and evaluated.   The present effort focused primarily on empirical studies with mammals.  

Empirical studies are focused on suppression of estrogen receptors and resulting epigenetic modifications, in support of development of AOP 651.

Authors of KER 3833 did a further evaluation of published peer-reviewed literature to provide additional evidence in support of the key event relationship.  The literature used to support this KER began with the test guidelines and followed to primary, secondary, and/or tertiary works concerning the relevant underlying biology.  In addition, search engines were used to target journal articles with terms ‘estrogen receptor suppression’, ‘estrogen’, and ‘epigenetic modifications’ order to locate representative empirical studies that support the key event relationship.  

Following initial human effort AOP development, artificial Intelligence (AI)-assisted literature search and synthesis, using EPA-AI GPT5, was used to identify additional literature, and draft Uncertainties and Inconsistencies content of this KER page. Additionally, EPA-AI GPT5 was also used to  check for additional text improvement in other sections. All content generated through this process were reviewed and verified by the KER author against literature sources, prior to inclusion.  

Evidence Supporting this KER

Addresses the scientific evidence supporting KERs in an AOP setting the stage for overall assessment of the AOP. More help
Biological Plausibility
Addresses the biological rationale for a connection between KEupstream and KEdownstream.  This field can also incorporate additional mechanistic details that help inform the relationship between KEs, this is useful when it is not practical/pragmatic to represent these details as separate KEs due to the difficulty or relative infrequency with which it is likely to be measured.   More help

Endocrine-disrupting compounds have been widely studied, with resulting disruptions to estrogen receptor activity.  Estrogen receptors have been evolutionarily conserved in vertebrates, and are key signallers in a variety of pathways.    Suppression of estrogen receptor activity leads to modification of downstream pathways of gene expression, including the levels of gene expression leading to proteins responsible for epigenetic modifications such as DNA methylation and the alteration of histone proteins.

Uncertainties and Inconsistencies
Addresses inconsistencies or uncertainties in the relationship including the identification of experimental details that may explain apparent deviations from the expected patterns of concordance. More help
  • Uncertainties in attribution to Estrogen receptors suppression.
    • Estrogen receptors are only one class of nuclear receptor that alters gene expression of pathways associated with epigenetic modifications such as DNA methylation and histone modifications in humans and laboratory rodents (Romagnolo et al. 2014); therefore it can be difficult to attribute epigenetic modifications solely to suppression of estrogen receptor activity, particularly for studies conducted with stressors that are not highly specific to ER.
  • Complications due to heterogeneity in tissue type.
    • Tissue contains a variety of cell types, particularly reproductive tissue with various ages in germ cells.  Care should be taken not to attribute a global pattern in epigenetic modification when there are heterogeneous cell-types present, which can be mitigated by single cell type studies in humans and laboratory rodents (Cui et al. 2025).

Known modulating factors

This table captures specific information on the MF, its properties, how it affects the KER and respective references.1.) What is the modulating factor? Name the factor for which solid evidence exists that it influences this KER. Examples: age, sex, genotype, diet 2.) Details of this modulating factor. Specify which features of this MF are relevant for this KER. Examples: a specific age range or a specific biological age (defined by...); a specific gene mutation or variant, a specific nutrient (deficit or surplus); a sex-specific homone; a certain threshold value (e.g. serum levels of a chemical above...) 3.) Description of how this modulating factor affects this KER. Describe the provable modification of the KER (also quantitatively, if known). Examples: increase or decrease of the magnitude of effect (by a factor of...); change of the time-course of the effect (onset delay by...); alteration of the probability of the effect; increase or decrease of the sensitivity of the downstream effect (by a factor of...) 4.) Provision of supporting scientific evidence for an effect of this MF on this KER. Give a list of references.  More help
Response-response Relationship
Provides sources of data that define the response-response relationships between the KEs.  More help
Time-scale
Information regarding the approximate time-scale of the changes in KEdownstream relative to changes in KEupstream (i.e., do effects on KEdownstream lag those on KEupstream by seconds, minutes, hours, or days?). More help
Known Feedforward/Feedback loops influencing this KER
Define whether there are known positive or negative feedback mechanisms involved and what is understood about their time-course and homeostatic limits. More help

Domain of Applicability

A free-text section of the KER description that the developers can use to explain their rationale for the taxonomic, life stage, or sex applicability structured terms. More help

Life Stage: All life stages as estrogen receptor signalling leading to epigenetic modifications affecting gene expression occur in all life stages.

Sex: Applies to both males and females.

Taxonomic: Largely studied in lab mammals; plausible for all vertebrates as estrogen receptors have been evolutionarily conserved, and epigenetic modifications are an inherent feature of DNA replication (Romagnolo et al. 2014; Fishman and Tauber 2024; Cui et al. 2025; Liu et al. 2025).  

References

List of the literature that was cited for this KER description. More help

Cui Y, Deng J, Zhang Y, Du L, Jiang F, Li C, Chen W, Zhang H, He Z. 2025. Epigenetic regulation by DNA methylation, histone modifications and chromatin remodeling complexes in controlling spermatogenesis and their dysfunction with male infertility. Cellular and Molecular Life Sciences 82(1): 343. 

Fishman B, Tauber E. 2024.  Epigenetics and seasonal timing in animals: a concise review. Journal of Comparative Physiology A: Neuroethology, Sensory, Neural, and Behavioral Physiology 210(4): 565-574.  

Gao Y, Zhao Y, Zhang H, Zhang P, Liu J, Feng Y, Men Y, Li L, Shen W, Sun Z, Min L. 2019.  Pubertal exposure to low doses of zearalenone disrupting spermatogenesis through ERα related genetic and epigenetic pathways. Toxicology Letters. 315: 31-38.

Liu J, Zhang P, Zhao Y, Zhang H. 2019.  Low dose carbendazim disrupts mouse spermatogenesis might be through estrogen receptor related histone and DNA methylation. Ecotoxicology and Environmental Safety 176: 242-249. 

Liu X, Nisa KUI, Kong W, Lang Z, and Niu Q. 2025. DNA methylation and histone modifications: conserved, divergent, and synergistic epigenetic regulation across plants and animals.  Epigenetics Insights 18: e015.

Men Y, Zhao Y, Zhang P, Zhang H, Gao Y, Liu J, Feng Y, Li L, Shen W, Sun Z, Min L. 2019.  Gestational exposure to low-dose zearalenone disrupting offspring spermatogenesis might be through epigenetic modifications. Basic and Clinical Pharmacology and Toxicology 125(4): 382-393.

Romagnolo DF, Zempleni J, Selmin OI. 2014. Nuclear receptors and epigenetic regulation: opportunities for nutritional targeting and disease prevention. Advances in Nutrition 5(4):373-385.

Ryu DY, Pang WK, Adegoke EO, Rahman MS, Park YJ, Pang MG. 2022.  Abnormal histone replacement following BPA exposure affects spermatogenesis and fertility sequentially. Environment International 170: 107617. 

U.S. Environmental Protection Agency.  2025.  EDSP Test Guidelines and Guidance Document. https://www.epa.gov/test-guidelines-pesticides-and-toxic-substances/edsp-test-guidelines-and-guidance-document (retrieved 25 July 2025).

Italics indicate edits from John Frisch July 2026.  A full list of updates can be found in the Change Log on the View History page.